Angiopoietin-1 and Angiopoietin-2 Inhibitors: Clinical Development

Jessica Gillen1, Debra Richardson1, Kathleen Moore2

  • 1The University of Oklahoma Stephenson Cancer Center, 800 NE 10th Street, Oklahoma City, OK, 73104, USA.

Current Oncology Reports
|February 27, 2019
PubMed
Abstract

Insights

Tie2-angiopoietin inhibition shows promise in reducing tumor growth and metastasis in preclinical studies. Clinical trial results are mixed, warranting further investigation for optimal use in cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • The Tie2-angiopoietin system is crucial for vascular development and homeostasis.
  • Dysregulation of this pathway contributes to tumor angiogenesis, growth, and metastasis.
  • Targeting Tie2 offers a potential therapeutic strategy for various cancers.

Purpose of the Study:

  • To review the current understanding of the Tie2-angiopoietin system in cancer.
  • To discuss preclinical and clinical data on Tie2-angiopoietin inhibition therapies.
  • To evaluate the efficacy and future potential of Tie2 inhibitors in oncology.

Main Methods:

  • Comprehensive literature review of preclinical models and clinical trials.
  • Analysis of data from studies evaluating Tie2-angiopoietin inhibitors.
  • Focus on tumor growth, metastasis, and therapeutic responses.

Main Results:

  • Tie2 inhibition demonstrated significant efficacy in preclinical cancer models, reducing tumor burden and metastasis.
  • Clinical trials with inhibitors like trebananib, rebastanib, and MEDI3617 have yielded mixed results.
  • Ongoing investigations explore Tie2-angiopoietin inhibitors in recurrent or metastatic breast and renal cell carcinomas.

Conclusions:

  • The Tie2-angiopoietin pathway remains a promising target for cancer therapy.
  • Further clinical evaluation is necessary to determine the optimal utility of Tie2 inhibitors.
  • Understanding the nuances of Tie2 inhibition in human trials is critical for advancing cancer treatment.

Related Concept Videos

Predicting Products: SN1 vs. SN202:27

Predicting Products: SN1 vs. SN2

Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
17.3K
Piaget's Stage 1 of Cognitive Development01:14

Piaget's Stage 1 of Cognitive Development

The sensorimotor stage, the initial phase of Jean Piaget's theory of cognitive development, spans the first two years of a child's life. During this period, infants actively engage with their surroundings, building cognitive awareness through direct interaction with the world. This interaction is primarily based on sensory perception and motor actions, allowing infants to gradually understand basic physical properties and predict how objects interact within their environment.
Exploration...
1.7K
Piaget's Stage 2 of Cognitive Development01:14

Piaget's Stage 2 of Cognitive Development

The preoperational stage, the second of Jean Piaget's four stages of cognitive development, spans approximately ages 2 to 7 and is characterized by the emergence of symbolic thinking. During this stage, children use language, images, and symbols to represent objects and concepts, enabling them to engage in imaginative and pretend play. This symbolic thinking supports children's ability to perform make-believe actions, such as imagining a broom as a horse or their hand as a phone, blending...
898
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
1° Amines to Diazonium or Aryldiazonium Salts: Diazotization with NaNO2 Overview01:26

1° Amines to Diazonium or Aryldiazonium Salts: Diazotization with NaNO2 Overview

Nitrous acid and nitric acids are two types of acids containing nitrogen, among which nitrous acid is weaker than nitric acid. Nitrous acid with a pKa value of 3.37 ionizes in water to give a nitrite ion and the hydronium ion.
The nitrous acid is unstable. Hence, it is formed in situ from a solution of sodium nitrite and cold aqueous acids such as hydrochloric or sulfuric acid. In an acidic solution, the –OH group of nitrous acid undergoes protonation to give oxonium ion, followed by...
3.9K
1° Amines to Diazonium or Aryldiazonium Salts: Diazotization with NaNO2 Mechanism01:37

1° Amines to Diazonium or Aryldiazonium Salts: Diazotization with NaNO2 Mechanism

Nitrous acid is a relatively weak and unstable acid prepared in situ by the reaction of sodium nitrite and cold, dilute hydrochloric acid. In an acidic solution, the nitrous acid undergoes protonation when it loses water to form a nitrosonium ion—an electrophile. Nitrous acid reacts with primary amines to give diazonium salts. The reaction is called diazotization of primary amines.
4.9K